OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Concise Reviews: Cancer Stem Cell Targeted Therapies: Toward Clinical Success
Amar Desai, Yan Yan, Stanton L. Gerson
Stem Cells Translational Medicine (2018) Vol. 8, Iss. 1, pp. 75-81
Open Access | Times Cited: 159
Amar Desai, Yan Yan, Stanton L. Gerson
Stem Cells Translational Medicine (2018) Vol. 8, Iss. 1, pp. 75-81
Open Access | Times Cited: 159
Showing 1-25 of 159 citing articles:
Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
Lia Walcher, Ann-Kathrin Kistenmacher, Huizhen Suo, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 768
Lia Walcher, Ann-Kathrin Kistenmacher, Huizhen Suo, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 768
Drug resistance and Cancer stem cells
Yuan Li, Zhenning Wang, Jaffer A. Ajani, et al.
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 236
Yuan Li, Zhenning Wang, Jaffer A. Ajani, et al.
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 236
Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer
Masahiro Shibata, Mohammad Obaidul Hoque
Cancers (2019) Vol. 11, Iss. 5, pp. 732-732
Open Access | Times Cited: 195
Masahiro Shibata, Mohammad Obaidul Hoque
Cancers (2019) Vol. 11, Iss. 5, pp. 732-732
Open Access | Times Cited: 195
Ferroptosis-driven nanotherapeutics for cancer treatment
Xinzhu Shan, Shumeng Li, Bingjun Sun, et al.
Journal of Controlled Release (2020) Vol. 319, pp. 322-332
Closed Access | Times Cited: 175
Xinzhu Shan, Shumeng Li, Bingjun Sun, et al.
Journal of Controlled Release (2020) Vol. 319, pp. 322-332
Closed Access | Times Cited: 175
Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies
Shihori Tanabe, Sabina Quader, Horacio Cabral, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 140
Shihori Tanabe, Sabina Quader, Horacio Cabral, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 140
MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic
Wen Li, Yunfei Wang, Ruifang Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 125
Wen Li, Yunfei Wang, Ruifang Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 125
Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid Tumors
Courtney L. Jones, Anagha Inguva, Craig T. Jordan
Cell stem cell (2021) Vol. 28, Iss. 3, pp. 378-393
Open Access | Times Cited: 111
Courtney L. Jones, Anagha Inguva, Craig T. Jordan
Cell stem cell (2021) Vol. 28, Iss. 3, pp. 378-393
Open Access | Times Cited: 111
Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity
Ryan C. Gimple, Kailin Yang, Matthew Halbert, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 9, pp. 497-514
Closed Access | Times Cited: 87
Ryan C. Gimple, Kailin Yang, Matthew Halbert, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 9, pp. 497-514
Closed Access | Times Cited: 87
NK cells are never alone: crosstalk and communication in tumour microenvironments
Yongqiang Zhou, Cheng Lu, Lu Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 85
Yongqiang Zhou, Cheng Lu, Lu Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 85
Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells
Farnaz Hajizadeh, Isobel Okoye, Maryam Esmaily, et al.
Life Sciences (2019) Vol. 237, pp. 116952-116952
Closed Access | Times Cited: 94
Farnaz Hajizadeh, Isobel Okoye, Maryam Esmaily, et al.
Life Sciences (2019) Vol. 237, pp. 116952-116952
Closed Access | Times Cited: 94
Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications
Claudia Peitzsch, Jacqueline Nathansen, Iñaki Schniewind, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 616-616
Open Access | Times Cited: 86
Claudia Peitzsch, Jacqueline Nathansen, Iñaki Schniewind, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 616-616
Open Access | Times Cited: 86
Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy
Subhayan Sur, Ratna B. Ray
Cancers (2020) Vol. 12, Iss. 8, pp. 2064-2064
Open Access | Times Cited: 75
Subhayan Sur, Ratna B. Ray
Cancers (2020) Vol. 12, Iss. 8, pp. 2064-2064
Open Access | Times Cited: 75
Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics
Neerada Meenakshi Warrier, Prasoon Agarwal, Praveen Kumar
Stem Cell Reviews and Reports (2020) Vol. 16, Iss. 5, pp. 828-852
Open Access | Times Cited: 72
Neerada Meenakshi Warrier, Prasoon Agarwal, Praveen Kumar
Stem Cell Reviews and Reports (2020) Vol. 16, Iss. 5, pp. 828-852
Open Access | Times Cited: 72
The effects of microgravity on differentiation and cell growth in stem cells and cancer stem cells
Daniela Grimm, Markus Wehland, Thomas J. Corydon, et al.
Stem Cells Translational Medicine (2020) Vol. 9, Iss. 8, pp. 882-894
Open Access | Times Cited: 71
Daniela Grimm, Markus Wehland, Thomas J. Corydon, et al.
Stem Cells Translational Medicine (2020) Vol. 9, Iss. 8, pp. 882-894
Open Access | Times Cited: 71
Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies
Markus H. Frank, Brian J. Wilson, Jason S. Gold, et al.
Gastroenterology (2021) Vol. 160, Iss. 6, pp. 1947-1960
Open Access | Times Cited: 71
Markus H. Frank, Brian J. Wilson, Jason S. Gold, et al.
Gastroenterology (2021) Vol. 160, Iss. 6, pp. 1947-1960
Open Access | Times Cited: 71
Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs
Qitong Wu, Sumit Siddharth, Dipali Sharma
Cancers (2021) Vol. 13, Iss. 15, pp. 3697-3697
Open Access | Times Cited: 67
Qitong Wu, Sumit Siddharth, Dipali Sharma
Cancers (2021) Vol. 13, Iss. 15, pp. 3697-3697
Open Access | Times Cited: 67
Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy
Hend M. Nawara, Said M. Afify, Ghmkin Hassan, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 500-500
Open Access | Times Cited: 63
Hend M. Nawara, Said M. Afify, Ghmkin Hassan, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 500-500
Open Access | Times Cited: 63
Reactive oxygen species-upregulating nanomedicines towards enhanced cancer therapy
Yuanyuan Ding, Qingqing Pan, Wenxia Gao, et al.
Biomaterials Science (2022) Vol. 11, Iss. 4, pp. 1182-1214
Closed Access | Times Cited: 51
Yuanyuan Ding, Qingqing Pan, Wenxia Gao, et al.
Biomaterials Science (2022) Vol. 11, Iss. 4, pp. 1182-1214
Closed Access | Times Cited: 51
Signaling pathways in the regulation of cancer stem cells and associated targeted therapy
Manni Wang, Wu Min
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 48
Manni Wang, Wu Min
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 48
Distinct features of iron based metal organic frameworks (MOFs) for ferroptosis mediated cancer therapy: A comprehensive review
Ritu Kudarha, Namdev Dhas, Srinivas Mutalik
Coordination Chemistry Reviews (2023) Vol. 494, pp. 215330-215330
Closed Access | Times Cited: 38
Ritu Kudarha, Namdev Dhas, Srinivas Mutalik
Coordination Chemistry Reviews (2023) Vol. 494, pp. 215330-215330
Closed Access | Times Cited: 38
Cellular Dormancy in Cancer: Mechanisms and Potential Targeting Strategies
Hyeyoung Min, Ho‐Young Lee
Cancer Research and Treatment (2023) Vol. 55, Iss. 3, pp. 720-736
Open Access | Times Cited: 29
Hyeyoung Min, Ho‐Young Lee
Cancer Research and Treatment (2023) Vol. 55, Iss. 3, pp. 720-736
Open Access | Times Cited: 29
KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer
Jiawen Bu, Yixiao Zhang, Sijin Wu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Jiawen Bu, Yixiao Zhang, Sijin Wu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy
Yaxin Wang, Yunmeng Liu, Jincheng Zhang, et al.
Acta Biomaterialia (2024) Vol. 176, pp. 51-76
Closed Access | Times Cited: 11
Yaxin Wang, Yunmeng Liu, Jincheng Zhang, et al.
Acta Biomaterialia (2024) Vol. 176, pp. 51-76
Closed Access | Times Cited: 11
Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies
Mohamed El‐Tanani, Syed Arman Rabbani, Shakta Mani Satyam, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 382-382
Open Access | Times Cited: 1
Mohamed El‐Tanani, Syed Arman Rabbani, Shakta Mani Satyam, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 382-382
Open Access | Times Cited: 1
Extracellular matrix-mediated regulation of cancer stem cells and chemoresistance
Yazmin Brown, Susan Hua, Pradeep S. Tanwar
The International Journal of Biochemistry & Cell Biology (2019) Vol. 109, pp. 90-104
Closed Access | Times Cited: 75
Yazmin Brown, Susan Hua, Pradeep S. Tanwar
The International Journal of Biochemistry & Cell Biology (2019) Vol. 109, pp. 90-104
Closed Access | Times Cited: 75
